How common is Prostate cancer?

['Yevelela emẽla eli']

Uveyi wo kanser wo prostata wa siata ndati?

O kanser yo prostata oyo yimue pokati kolokanser via siata vali calua kalume, ca piãla vali enene akulu.

Ndomo ca lomboluiwa lo Sociedade Americana do Câncer, o câncer de próstata oyo o câncer yavali vali calua yalume vo Estados Unidos, noke yo câncer de pele.

Ko Estados Unidos, ulume umosi pokati keci ci soka 9 o ka kuatiwa luvei wo kanser yo prostata vokuenda kuomuenyo waye.

Kunyamo wo 2021, kua limbukiwa okuti ku ka kala eci ci soka 248.530 kovoveyi okaliye o kanser yo prostata kuenda eci ci soka 34.130 komanu va ka fa lo kanser yo prostata.

Pole, nda o kuete uveyi waco, o sukila oku limbuka lonjanga okuti, citava oku u sakula.

['Atosi a Velapo']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Fesinmeyer MD, Gulati R, Zeliadt S, Weiss N, Kristal AR, Etzioni R: Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States. Cancer Epidemiol Biomarkers Prev. 2009, 18 (3): 808-15.

Peng P, Gong YM, Bao PP, Ke JZ, Xiang YM, Zhang ML, Zheng Y: [Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008]. Zhonghua Liu Xing Bing Xue Za Zhi. 2012, 33 (10): 1056-9.

Delongchamps NB, Singh A, Haas GP: The role of prevalence in the diagnosis of prostate cancer. Cancer Control. 2006, 13 (3): 158-68.

Li J, German R, King J, Joseph D, Thompson T, Wu XC, Ajani U, Tai E: Recent trends in prostate cancer testing and incidence among men under age of 50. Cancer Epidemiol. 2012, 36 (2): 122-7.

Yu XQ, Luo Q, Smith DP, Clements MS, O'Connell DL: Prostate cancer prevalence in New South Wales Australia: a population-based study. Cancer Epidemiol. 2015, 39 (1): 29-36.

Ondrusova M, Mrozova L, Ondrus D, Mrinakova B: Trends and estimates in prostate cancer incidence, mortality and prevalence in the Slovak Republic, 1968-2012. Neoplasma. 2013, 60 (4): 446-51.

['Oku yuvula oku litenga vovitangi:']

['O Web site eyi, ya sandekiwila lika oku longisa omanu kuenda oku va ĩha olonumbi.']

['Nda o yongola oku sakuiwa, sandiliya ondotolo yi kuete uloño woku ci linga.']

['Kũlĩhĩsa okuti, uloño woku konomuisa atambululo apulilo, ka u pondola oku eca atambululo a suapo, ca piãla enene nda etendelo liaco ka lia suilepo.']

['Olonjanja viosi sandiliya ekuatiso liondotolo yove ale liondotolo yikuavo ya loñoloha kueci catiamẽla kocitangi cimue cuhayele. Lalimue eteke ku ka sepule ekuatiso liondotolo ale oku livala koku sandiliya omo liocina cimue wa tanga vo website yilo. Nda o sima okuti o kuete ocitangi cimue cuhayele, vilikiya lonjanga o 911 ale enda lonjanga kosipitali. Ka kuli ukamba umue pokati kondotolo lukuenje wa vela omo lio website yilo ale oku talavaya layo.']

['Oku liyelisa: omoko yoku soneha']

['O Digital Millennium Copyright Act yo 1998, 17 U.S.C. § 512 (o DMCA) yeca epondolo kolonalavayi vi kuete omoko yoku linga eci va sima okuti ovina vi sangiwa vo Internet vi nyõla omoko yavo yi sangiwa vocihandeleko co Estados Unidos. ']

['Nda ove o tava okuti ovina vimue via kapiwa vo Internet ale vovipama vikuavo vi kasi vonumbi yetu vi nyõla omoko yove yoku panga alivulu, ove (ale omunu wa ku nõla) o pondola oku tu tumisa esapulo limue oco tu piñale ovina viaco ale oku vi tateka.']

['Asapulo te a tumiwa loku soneha kuenda vo email (tala vokakasia "Kontato" oco o sange onumbi yo email).']

['DMCA yi kisika okuti esapulo liove lioku lavisa ovihandeleko viovihandeleko viupange mua kongela asapulo akuãimo: (1) elomboluilo liupange u kuete ovihandeleko viupange okuti owo wa lavisiwa; (2) elomboluilo liupange u kuete ovihandeleko viupange kuenda asapulo a tẽla oku ecelela oku sanga upange waco; (3) asapulo oku ku sandiliya, oku kongelamo onumbi yove, etendelo liotelefone kuenda onumbi yo email; (4) esapulo liove okuti ove o kuete ekolelo liwa okuti upange waco ka wa taviwile la muẽliaco ovihandeleko viupange, ale onumiwa yaye, ale oku kuama ovihandeleko; ']

['(5) ukanda umue wa sinaliwa love okuti u lekisa okuti esapulo liaco liocili kuenda o kuete omoko yoku teyuila omoko yove yoku soneha.']

['Kuenda (6) ondimbukiso yocikuata ale yo komputador yomunu ukuete omoko yoku linga upange waco ale yomunu umue o kuete omoko yoku linga upange waco vonduko yomunu ukuete omoko yaco. ']

['Nda kua kongelele ulandu wosi wa tukuiwa ndeti, ci tava okuti o livala poku tetulula ocitangi cove.']

['Oku Sapela']

['Tu tumise o email lapulilo ale ovisimĩlo viove.']

How common is prostate cancer?

Prostate cancer is one of the most common types of cancer in men, particularly in older men.

According to the American Cancer Society, prostate cancer is the second most common cancer in American men, behind skin cancer.

In the United States, about 1 in 9 men will be diagnosed with prostate cancer during their lifetime.

In 2021, it is estimated that there will be about 248,530 new cases of prostate cancer and about 34,130 deaths from prostate cancer.

However, it is important to note that prostate cancer is highly treatable, and the survival rate is high when it is detected early.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.